Dexterra Group Inc.
Dexterra Group Inc. (HZNOF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Dexterra Group Inc. (HZNOF), covering cash flow, earnings, and balance sheets.
Dexterra Group Inc. (HZNOF) Income Statement & Financial Overview
Review Dexterra Group Inc. HZNOF income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $239.73M | $247.76M | $269.75M | $253.62M |
| Cost of Revenue | $198.80M | $207.65M | $223.05M | $220.34M |
| Gross Profit | $40.94M | $40.10M | $46.70M | $33.29M |
| Gross Profit Ratio | $0.17 | $0.16 | $0.17 | $0.13 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $18.13M | $14.55M | $16.52M | $13.53M |
| Operating Expenses | $27.74M | $24.18M | $25.04M | $13.53M |
| Total Costs & Expenses | $226.53M | $231.83M | $248.08M | $233.87M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2.06M | $2.36M | $3.34M | $3.53M |
| Depreciation & Amortization | $9.58M | $9.61M | $8.89M | $8.60M |
| EBITDA | $23.02M | $25.26M | $30.39M | $28.36M |
| EBITDA Ratio | $0.10 | $0.10 | $0.11 | $0.11 |
| Operating Income | $13.20M | $15.93M | $21.66M | $19.76M |
| Operating Income Ratio | $0.06 | $0.06 | $0.08 | $0.08 |
| Other Income/Expenses (Net) | -$1.82M | -$2.65M | -$3.50M | -$3.53M |
| Income Before Tax | $11.38M | $13.28M | $18.17M | $16.25M |
| Income Before Tax Ratio | $0.05 | $0.05 | $0.07 | $0.06 |
| Income Tax Expense | $2.76M | $5.70M | $4.81M | $3.92M |
| Net Income | $8.57M | $6.85M | $7.66M | $8.98M |
| Net Income Ratio | $0.04 | $0.03 | $0.03 | $0.04 |
| EPS | $0.14 | $0.11 | $0.12 | $0.14 |
| Diluted EPS | $0.14 | $0.11 | $0.12 | $0.14 |
| Weighted Avg Shares Outstanding | $62.87M | $62.86M | $64.00M | $64.11M |
| Weighted Avg Shares Outstanding (Diluted) | $63.63M | $62.86M | $64.27M | $64.34M |
Over the last four quarters, Dexterra Group Inc.'s revenue moved from $253.62M in Q2 2024 to $239.73M in Q1 2025. Operating income in Q1 2025 was $13.20M, with a strong operating margin of 6%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Dexterra Group Inc. remained robust at $23.02M, reflecting operational efficiency. Net income rose to $8.57M, with an EPS of $0.14. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan